Advanced Enzyme Technologies Ltd Share Price – NSE  /  BSE

Pharmaceuticals, Small Cap

On the segmental front, the revenue from human nutrition segment increased by 19% to Rs 110.7 crore in Q3 FY24 from Rs 93.4 crore in Q3 FY23. This growth was on account of API, probiotics and nutrition.

Animal nutrition segment revenue declined by 8% to Rs 16.2 crore in Q3 FY24 from Rs 17.5 crore in Q3 FY23.

The Bio-Processing segment revenue was at Rs 23.6 crore in Q3 FY24, up by 5% YoY. In this segment, food business performed well, it grew by 21% to Rs 19.3 crore on YoY basis during Q3 FY24. The Non-Food business de-grew by 36% to Rs 4.3 crore during the quarter.

The Specialized manufacturing segment contributed 6% in the pie which is Rs 10.4 crore to the revenue during the quarter, an increase of 20% on YoY basis.

The domestic sales constituted about 48% of revenue from operations during Q3 FY24 as compared to 42% during Q3 FY23. International sales were 52% of revenue from operations during Q3 FY24 as compared to 58% during Q2 FY23.

EBITDA improved by 29% YoY to Rs 53.8 crore in the third quarter. EBITDA margin was 33% in Q3 FY24 as against 29% in Q3 FY23.

Profit before tax stands at Rs 58.9 crore during Q3 FY24 as against Rs 40.4 crore in Q3 FY23, an increase of 46%.

Advanced Enzyme Technologies is a research driven company with global leadership in the manufacturing of enzymes and probiotics. The company provides eco-safe solutions to a wide variety of industries like human health care and nutrition, animal nutrition, baking, fruit & vegetable processing, brewing & malting, grain processing, protein modification, dairy processing, specialty applications, textile processing and others. Its aim is to replace traditionally used chemicals with eco-friendly enzymatic solutions.

Powered by Capital Market - Live News

Net profit of Advanced Enzyme Technologies rose 41.88% to Rs 41.77 crore in the quarter ended December 2023 as against Rs 29.44 crore during the previous quarter ended December 2022. Sales rose 13.25% to Rs 160.94 crore in the quarter ended December 2023 as against Rs 142.11 crore during the previous quarter ended December 2022.

Powered by Capital Market - Live News

Advanced Enzyme Techs. will hold a meeting of the Board of Directors of the Company on 10 February 2024.

Powered by Capital Market - Live News

Net profit of Advanced Enzyme Technologies rose 31.29% to Rs 34.41 crore in the quarter ended September 2023 as against Rs 26.21 crore during the previous quarter ended September 2022. Sales rose 13.81% to Rs 157.84 crore in the quarter ended September 2023 as against Rs 138.69 crore during the previous quarter ended September 2022.

Powered by Capital Market - Live News